VisionGuard Completes Tens of Millions RMB Pre-A Financing to Advance Eye Health Solutions
Wellsees
Innovative Ophthalmic Medical Device Developer
VCBeat learned exclusively,Committed to building a leading brand for comprehensive eye health solutions——Wellsees(hereinafter referred to as "Wellsees"") announced the completion of a Pre-A round of financing worth tens of millions of RMB, exclusively invested by Blue Bay Sci-Tech Group. The funds raised will be used for the clinical registration of the company's core projects.
Wellsees, founded in November 2019, is one of the few companies in China that masters the full-process technology of corneal contact lens design, processing, and fitting. Since its establishment, Wellsees has been committed to becoming the most trustworthy ophthalmic medical technology enterprise in China. It has deeply engaged in scientific research in optometry and is dedicated to solving the vision health problems of the Chinese people, using technological innovation to make the visual world of the Chinese healthier, freer, and clearer.
The company team is composed of professional elites, including the professor team from the Department of Optometry at Hong Kong Polytechnic University, the professor team from Shenzhen University, as well as technical talents and senior management from Huawei and Mindray.
Wellsees officially landed in Xianju, Taizhou, Zhejiang in August 2023, establishing the Wellsees East China Base Camp, achieving advantageous linkage between South and East China, and comprehensively promoting the industrial development of optometry and optical services.
Wellsees has built a one-stop solution medical device product line focused on eye health, includingFull-lens toric orthokeratology lenses (OK lenses), RGP, scleral lenses, portable corneal topography, and intelligent AI fitting system, etc. Currently, all commercialization efforts of the company are proceeding rapidly and in an orderly manner.
In addition to rapid progress in products, Wellsees has also shone brightly in various competitions——Won the "First Prize" in the Xianju District and "Third Prize" in the Taizhou District at the 8th "Maker China" and "Zhejiang Good Projects" SME Innovation and Entrepreneurship Competition; advanced to the final of the Longgang District at the 15th Shenzhen Innovation Competition and the 3rd Longgang Dual Innovation Star Innovation and Entrepreneurship Competition.
For this round of financing,Wellsees Founder Zhang JingRepresentation: Under the strong execution of Professor Ji, Professor Wang, the co-founders of the company, and all colleagues, Wellsees has achieved rapid development in various tasks. Significant breakthroughs have been made in product development, clinical registration, and more. We deeply thank our original shareholders and new investment shareholder, Chairman Deng of Lanwan Sci-Tech Group, for their support and recognition. As a comprehensive solution provider for eye health, Wellsees possesses unparalleled research and development capabilities and technological innovation strength. The company’s independently developed next-generation orthokeratology lenses (OK lenses) have demonstrated remarkable clinical results in experimental trials in Hong Kong and registered clinical trials at six of China's top optometry hospitals. Overseas sales of the company’s products have also received high praise from customers for their extraordinary comfort, perfect vision correction effects, and rapid delivery capabilities. This Pre-A round of financing will accelerate Wellsees' market layout in South China, East China, and Southeast Asia, as well as expedite market promotion and the building of an excellent team. Wellsees will continue to uphold its original mission, using technological innovation to make the world of vision healthier.
Deng Jianxin, Founder of Blue Bay Innovation GroupEye health occupies a very important position in people's healthy lives. The eye health industry is a policy-oriented industry in China and will be a supported sector in the coming decades, holding significant social value. Wellsees is a rising star in the eye health sector, equipped with strong professional technology and an excellent team. Empowered by AI, it provides integrated services for myopia prevention and control as well as eye health management. With synchronized efforts in both domestic and overseas markets, its competitive strength is evident. We look forward to supporting Wellsees in continuous innovation and rapid development, confident that in the future, Wellsees will become an influential leader in the field of optometry and eye health.
About Blue Bay Sci-Tech Group
Blue Bay Sci-Tech Group is an innovative industrial ecosystem operator focusing on the life and health industry. With the basic business model of "industry + platform + capital + operation," it centers on industrial investment, with industrial operation and industrial services as its two wings. It is committed to building a regional innovation and entrepreneurship ecosystem along with the Blue Bay standard industrial ecosystem.
Blue Bay Sci-Tech currently manages 5 industry funds with a total scale exceeding 1.5 billion yuan, focusing on early-stage investments, particularly angel round projects. It has cumulatively invested in approximately 50 high-tech life science and health projects. Investment cases include Aosikang Biopharmaceuticals, Jingze Biotech, Yiying Technology, Haitai Biotech, Nolaisen Technology, Huyun New Drug, Notan Pharmaceuticals, Huiwei Medical, Tanyin Medicine, Tongxuan Medical, Yike Polymers, Hanye Medical, Dassence Medical, and others.
At the same time, Blue Bay Sci-Tech is deeply involved in the comprehensive development and operation of regional areas, always adhering to the concept of "industry as the foundation, talent as the base, ecology as the soul, platform as the tool, capital as the core, and operation as the king." It has assisted the government in building characteristic industrial clusters such as the Haimen Biomedical Town, Xianju Medical Device Town, Hanzhong Nuclear Medicine Industrial Park, and Dongying Animal Protection Biomedical Industrial Park. Striving to become the best accelerator in China's biomedicine field.
Recommended Reading: